Recital 3, Commission Implementing Regulation (EU) No 198/2013 of 7 March 2013 on the selection of…

In forcesince 7 Mar 2013

To ensure transparency, all medicinal products that are subject to additional monitoring are included in a list that is set up and maintained by the European Medicines Agency in accordance with Article 23(1) of Regulation (EC) No 726/2004. Additionally, they are labelled with a black symbol.